What you need to know about the BRCA1 & how it can lead to breast cancer
Angelina Jolie's stunning announcement that she had a preventive double mastectomy has raised both awareness and questions about the gene that led to her decision called BRCA1.
PathVisio-Faceted Search: an exploration tool for multi-dimensional navigation of large pathways
The plugin then provides a filtering mechanism, known as a faceted search, to find and highlight diagram nodes of interest based on imported data.
Agenus begins Phase 2 trials of brain tumor vaccine
Stock in Agenus Inc. rose more than 4 percent after the company announced it's started enrolling patients in what it says is the largest vaccine trial ever funded by the National Cancer Institute in brain tumors.
Mon May 20, 2013
Applied Clinical Trials
TRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract...
TRC105, a novel monoclonal antibody to endoglin , is being studied in multiple clinical trials in combination with agents that target the VEGF pathway.
Sat May 18, 2013
Conventional medicine openly admits to confusion over BRCA1 gene
I nearly fell off my chair. Even if you test positive for the BRCA1 gene mutation - your risk of getting breast cancer may still be caused by other factors.
Thu May 16, 2013
Kite Pharma, Inc. Locks in $20 Million From Big Investors
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Kite Pharma Completes $35 Million Series A Preferred Stock Financing LOS ANGELES /PRNewswire/ -- Kite Pharma Inc.
Wed May 15, 2013
In the article by Silvestre-Roig et al, which appeared in the May 2013 issue of the journal , the current address for Patricia FernA ndez should have been: National Cancer Institute, National Institutes of Health, 41 Library Drive, Bldg 41, B513, Bethesda, MD 20892.
First prospective trial shows molecular profiling timely for tailoring therapy
A clinical trial has shown that patients, and their physicians, are eager to jump into next-era cancer care - analysis of an individual's tumor to find and target genetic mutations that drive the cancer.
Tue May 14, 2013
What's the gene that led to Angelina Jolie's double mastectomy?
Angelina Jolie's stunning announcement that she had a preventive double mastectomy raised both awareness and questions about the gene that led to her decision -- BRCA1.
Wed May 08, 2013
Science, Industry and Business
Cancer Biorepository Speeds Clinical Trials, Drug Development, Moffitt Analysis Shows
Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug development pipeline.
Mon May 06, 2013
Using DCIS Score To Quantify Risk Of IBE For Breast Cancer Patients
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published in the ... (more)
Sat May 04, 2013
E. Frei put cancer cures in reach
Dr. Emil Frei III, an oncologist whose trailblazing use of combination chemotherapy -- in which anti-cancer drugs are administered simultaneously rather than singly -- helped make certain cancers curable for the first time, died Tuesday, April 30, at his home in Oak Park, Ill.
Fri May 03, 2013
Medical News Today
Mutations Discovered That May Affect Treatment Of Patients With Endometrial Cancer
Main Category: Cancer / Oncology Also Included In: Genetics ; Women's Health / Gynecology Article Date: 03 May 2013 - 1:00 PDT A study from the Cancer Genome Atlas Research Network, led by the National Cancer Institute and the National Human Genome Research Institute, report that mutations discovered in endometrial cancer genes may directly impact ... (more)
Thu May 02, 2013
DCIS Score quantifies risk of ipsilateral breast event
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in ... (more)
Cancer Genetics, Inc. Launches Proprietary Microarray for Kidney Cancer
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Rutherford, May 2, 2013 -- Cancer Genetics, Inc.
The Cancer Institute of New Jersey Expands its Statewide Network
Shore Medical Center is pleased to announce it has entered into an affiliation agreement with The Cancer Institute of New Jersey - the state's only National Cancer Institute-designated Comprehensive Cancer Center.
Wed May 01, 2013
A paradigm shift in endometrial cancer
A study from the Cancer Genome Atlas Research Network, led by the National Cancer Institute and the National Human Genome Research Institute, report that mutations discovered in endometrial cancer genes may directly impact treatment plans for women with aggressive endometrial cancer, as well as the classification of endometrial cancer tumors.
Mon Apr 29, 2013
Cancer Cells Are Nimbler Than Non-Malignant Cells
Clues about how cells become cancerous are revealed in a new catalogue of their physical and chemical features.
Fri Apr 26, 2013
Stomach cancer is cancer that occurs in the stomach - the muscular sac located in the upper middle of your abdomen, just below your ribs.